trending Market Intelligence /marketintelligence/en/news-insights/trending/_gi9mp8hnldw5trgcow5rw2 content esgSubNav
In This List

Tetraphase Pharmaceuticals CFO resigns

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


Tetraphase Pharmaceuticals CFO resigns

Tetraphase Pharmaceuticals Inc. said Kamalam Unninayar resigned as CFO on March 16.

Unninayar joined the Watertown, Mass.-based antibiotics developer in October 2017.

Senior Vice President of Finance Christopher Watt will act as principal financial officer and principal accounting officer until a replacement CFO is named, Tetraphase said in a filing.